Characteristics and Management of Children with COVID-19 in Turkey

Burcu Ceylan Cura Yayla1, Yasemin Özsürekçi2, Kübra Aykaç1

  • 1Department of Pediatric Infectious Diseases, University of Health Science Turkey, Ankara Training and Research Hospital, Ankara, Turkey

Balkan Medical Journal
|September 1, 2020
PubMed

Insights

This study analyzed 220 pediatric coronavirus disease-2019 cases in Turkey, finding that while most cases are mild, critical illness necessitates supportive care. Data aids understanding pediatric COVID-19 disease management.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Critical Care Medicine

Background:

  • Limited data exists on pediatric coronavirus disease-2019 (COVID-19) management strategies, especially in Turkey.
  • Understanding the disease course in children is crucial for effective healthcare planning.

Purpose of the Study:

  • To share data on pediatric COVID-19 patients in Turkey (under 18 years).
  • To contribute to the understanding of COVID-19's clinical presentation and management in children.

Main Methods:

  • Retrospective review of medical records for pediatric patients (<18 years) diagnosed with COVID-19.
  • Data collected between March 11 and June 23, 2020, from admitted patients.

Main Results:

  • 220 pediatric COVID-19 patients evaluated; median age 10 years, 9.5% with comorbidities.
  • Severity distribution: 25.5% asymptomatic, 45% mild, 26.8% moderate, 2.7% critical/severe.
  • 0.9% required ECMO, 1.4% mechanical ventilation; 2.7% received targeted therapies (hydroxychloroquine/favipiravir).

Conclusions:

  • While pediatric COVID-19 often presents mildly, critical illness occurs and requires attention.
  • Preliminary observations suggest supportive care is the primary treatment strategy for pediatric COVID-19.
Abstract

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
300
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
376
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
334
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.1K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
95